Skip to main content
Caplight Logo









DCN Diagnostics

DCN Diagnostics

Private
Carlsbad, CaliforniaHealthcare & Life Scienceshttps://dcndx.com/

Last Round

Growth Equity

Nov 3, 2020

Company Overview

DCN Diagnostics is a biotechnology company that provides contract development, manufacturing, and clinical research services for in vitro diagnostic (IVD) products.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Compliance

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

lateral flow assayCDMOCROin vitro diagnosticsIVDdiagnostic test developmentpoint-of-care testingPOCTregulatory consultingclinical validationassay manufacturingdiagnostic readermedical device consultingrapid diagnostic testbiotech outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DCN Diagnostics Comparables

Compare DCN Diagnostics with similar companies based on industry and business-model similarity.

DCN Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Abingdon Health Plc
91%
True Diagnostics, Inc.
83%
Fortis Life Sciences
82%

DCN Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityNov 3, 2020

Key People

Founding team and executive leadership

Angela Rapattoni

Chief Financial Officer

Executive Team

Patrick Vaughan

Chief Operating Officer

Executive Team

DCN Diagnostics Investors

Notable investors and investment history

DCN Diagnostics investors
InvestorRounds
Martis Capital ManagementGrowth Equity

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 31, 2026

    Monthly visitors increased 62% MoM, reaching 12.7K.

  • Jun 1, 2025

    Monthly visitors increased 91% MoM, reaching 10.1K.

DCN Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DCN Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DCN Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCarlsbad, California
Employee Range63
Year Founded2002
Last FundingNov 3, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?